Patents-Review.com
🔗 Permalink
Inventor profile of:

Mark Edward Ruppen

City:

Garnerville, New York

Country:

United States

Published Applications:

32

Last publication date:

2021-01-28

Top Assignees for applications by Mark Edward Ruppen

The entities that hold a legal rights for patent applications filed by inventor Ruppen Mark Edward:

Recent patent applications by Ruppen Mark Edward

Mark Edward Ruppen from Garnerville, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2021-01-28
US20210024903A1
Chemistry; metallurgy

Compositions and methods relating to a mutant toxin

 #2 | 2020-02-27
US20200061177A1
Human necessities

compositions and methods thereof

 #3 | 2019-07-04
US20190202873A1
Chemistry; metallurgy

Compositions relating to a mutant clostridium difficile toxin and methods thereof

 #4 | 2019-05-16
US20190142922A1
Human necessities

Group B polysaccharide-protein conjugates, methods for producing conjugates, immunogenic compositions comprising conjugates, and uses thereof

 #5 | 2019-05-02
US20190125861A1
Human necessities

RSV F protein mutants

 #6 | 2019-04-18
US20190112584A1
Chemistry; metallurgy

Compositions and methods relating to a mutant toxin

 #7 | 2018-11-29
US20180339058A1
Human necessities

CALICHEAMICIN DERIVATIVE-CARRIER CONJUGATES

 #8 | 2018-06-28
US20180177864A1
Human necessities

RSV F protein mutants

 #9 | 2017-11-16
US20170326222A1
Human necessities

Non-lipidated variants of ORF2086 antigens

 #10 | 2017-06-29
US20170182151A1
Human necessities

RSV F protein mutants

 #11 | 2016-11-10
US20160324950A1
Human necessities

Group B polysaccharide-protein conjugates, methods for producing conjugates, immunogenic compositions comprising conjugates, and uses thereof

 #12 | 2016-10-20
US20160303252A1
Human necessities

CALICHEAMICIN DERIVATIVE-CARRIER CONJUGATES

 #13 | 2015-10-15
US20150291940A1
Chemistry; metallurgy

Compositions and methods relating to a mutant clostridium difficile toxin

 #14 | 2015-05-14
US20150132336A1
Human necessities

Immunogenic compositions of antigens

 #15 | 2014-08-21
US20140235835A1
Human necessities

Calicheamicin derivative-carrier conjugates

 #16 | 2014-06-10
US10699874
-

Calicheamicin derivative-carrier conjugates

 #17 | 2014-01-16
US20140017271A1
Human necessities

Immunogenic compositions of antigens

 #18 | 2012-08-23
US20120213804A1
Human necessities

Calicheamicin derivative-carrier conjugates

 #19 | 2012-05-03
US20120107327A1
Human necessities

Immunogenic compositions of antigens

 #20 | 2012-04-10
US10428894
-

Calicheamicin derivative-carrier conjugates

 #21 | 2011-06-23
US20110151546A1
Chemistry; metallurgy

Glycopeptide antibiotics

 #22 | 2009-04-23
US20090105461A1
Chemistry; metallurgy

Calicheamicin conjugates

 #23 | 2008-01-17
US20080014614A1
Chemistry; metallurgy

Labeling of rapamycin using rapamycin-specific methylases

 #24 | 2008-01-08
US10844195
-

Production of bicyclic-heteroaryl-2-carboxylic acids by selective enzymatic hydrolysis of a mixture of positional esters

 #25 | 2006-10-12
US20060228381A1
Human necessities

Separation of contaminants from polysaccharide by pH manipulation

 #26 | 2006-02-07
US10672788
-

Processing for preparing monoprotected diols from symmetric diols

 #27 | 2006-01-05
US20060002942A1
Chemistry; metallurgy

Calicheamicin conjugates

 #28 | 2005-12-29
US20050288221A1
Chemistry; metallurgy

Glycopeptide antibiotics

 #29 | 2005-11-15
US10131847
-

Glycopeptide antibiotics

 #30 | 2005-10-27
US20050239178A1
Chemistry; metallurgy

Labeling of rapamycin using rapamycin-specific methylases

 #31 | 2005-08-04
US20050171077A1
Human necessities

Compositions containing piperacillin and tazobactam

 #32 | 2005-07-05
US10131890
-

Glycopeptide antibiotics
InventorID:

613708 ⎘